$AKBA

2 theses

bullish 50%neutral 50%bearish 0%

Avg return (3d)

+14.0%

Win rate (3d)

100% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 27, 4:45 PM ET

$AKBAr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄neutral

u/Avish_Golakiya · 118d ago31 prior · 63% at 3mo

“long several of these”

5 of the 6 biotech names I posted 5 weeks ago hit their catalyst (and the 1 that hasn't)

No catalyst executed yet and thesis remains intact but unproven. Author sized it as riskiest position (~0.5%) and stock is roughly flat; waiting for dated catalyst confirmation.

At post $1.24Now $0.66-46.7% since postedas of Oct 27, 4:45 PM ET

1d—

3d—

1w+15.3%

1m+6.5%

3m-25.8%

6m—

1y—

original post →

$AKBAr/pennystocksꉓꍏ꓄ꍏ꒒ꌩꌗ꓄bullish

u/Avish_Golakiya · 135d ago31 prior · 63% at 3mo

“Start small, maybe 0.5% NAV, and scale toward 1.5% as it plays out”

Upcoming penny stock catalysts for June/July 2026 in Biotech and Pharma

AKBA trades at ~$280M market cap with $162M cash, leaving minimal enterprise value for ~$230M revenue. Asymmetric risk/reward at $1.04 with execution risk, suitable for small position sizing.

At post $0.94Now $0.66-29.7% since postedas of Oct 27, 4:45 PM ET

1d+4.8%

3d+14.0%

1w+16.1%

1m+47.0%

3m+1.4%

6m—

1y—

original post →

End of results.